Pharma Journalist -

SMi Reports: The only B2B parallel trade conference in Europe This conference will bring together industry experts to discuss the challenges and drivers of the industry, including…
Read More...

SMi Reports: The Virtual conference now only 2 weeks away The upcoming virtual conference now only 2 weeks away will bring together industry experts from leading RNA therapeutics…
Read More...

Eli Lilly and Company  announced the successful completion of its acquisition of Prevail Therapeutics Inc. The acquisition establishes a new modality for drug discovery and development…
Read More...

Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, announces a significant breakthrough in the identification of…
Read More...

SMi Group Reports: Six key microbiology presentations from FDA, STERIS, Boehringer Ingelheim Microbiological Consulting, Parexel will be discussed at SMi’s 4th Annual Pharmaceutical…
Read More...

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, announced the initiation of a two-part, four-arm, human safety and efficacy trial…
Read More...

Servier, a global and independent pharmaceutical Group, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced a research partnership to identify and develop small…
Read More...

Mitsubishi Tanabe Pharma America, Inc. and Aquestive Therapeutics, Inc. announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN (riluzole), an oral film…
Read More...

Akron Biotechnology, LLC (Akron Biotech), announced it has signed an exclusive global agreement to manufacture virally inactivated Human AB Serum for the cell therapy market using…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and…
Read More...